| Page 1784 | Kisaco Research
 

Todd B. Richter C.F.A

Senior Managing Director, Global Healthcare Investment Banking Group
Guggenheim Partners

Todd Richter is currently a Senior Managing Director at Guggenheim Partners. His primary focus is on the healthcare services field including managed care/payer services, physician-related businesses and all forms of distribution and outsourcing. In addition, Mr. Richter is responsible for Guggenheim Partners’ coverage of the global animal health field. From 2016 until 2018 Mr. Richter was Vice Chairman of Global Banking at Barclays.

Todd B. Richter C.F.A

Senior Managing Director, Global Healthcare Investment Banking Group
Guggenheim Partners

Todd B. Richter C.F.A

Senior Managing Director, Global Healthcare Investment Banking Group
Guggenheim Partners

Todd Richter is currently a Senior Managing Director at Guggenheim Partners. His primary focus is on the healthcare services field including managed care/payer services, physician-related businesses and all forms of distribution and outsourcing. In addition, Mr. Richter is responsible for Guggenheim Partners’ coverage of the global animal health field. From 2016 until 2018 Mr. Richter was Vice Chairman of Global Banking at Barclays. From 1999 to 2016 Todd Richter was a Senior Managing Director in the Global Healthcare Corporate & Investment Banking Group at Bank of America Merrill Lynch. From 1981 to 1999, Mr. Richter served as the head of the healthcare services analytical team for Morgan Stanley. Todd Richter earned a B.B.A. in Finance from the College of William & Mary in 1979 and an M.B.A. in Finance with Honors from Indiana University in 1981. Todd was recognized 16 times as a member of the Institutional Investor’s All-America Research Team. He was also listed many times among the Wall Street Journal’s “All-Star” analysts and on the Reuters research poll. Mr. Richter is currently a member of the Board of Directors (Vice Chairman) of Bideawee, one of the nation’s leading animal rescue organizations; a member of the Board of Directors at the Stratton Mountain School (SMS) in Stratton, Vermont, a member of the Board of Directors at Animal Lighthouse Rescue (ALR), and a member of the Dean’s Council for the Kelley School of Business at Indiana University.  Finally Mr. Richter is on the Board and faculty of the Columbia University Mailman School of Public Health teaching a course on healthcare consolidation to MPH and MHA candidates. 

Beauty Spotlight Finalists 2018
 
Beauty and Money NYC 2019
26 Sep 2019
New York, NY, USA
250+ beauty industry executives, from strategic buyers, financial buyers, retailers and independent beauty brands, all looking for their next investment, acquisition or business partnering opportunity.
 

Scott DeWire

Global Head of Business Development for Cancer Immunology
Boehringer Ingelheim

Scott is responsible for immuno-oncology partnerships and licensing at Boehringer Ingelheim Pharmaceuticals Inc.  Scott learned to pipette as an intern and later bench scientist with Pfizer Animal Health in his hometown of Groton, CT.  After Pfizer, he earned a PhD from the University of North Carolina, and completed his postdoc at Duke University with Robert Lefkowitz (2012 Nobel Prize).  Out of his postdoc, Scott co-founded Trevena Inc, a biotech company focused on GPCR biology.  Since joining Boehringer in 2012, Scott has held various roles in the research group before joining BD&L i

Scott DeWire

Global Head of Business Development for Cancer Immunology
Boehringer Ingelheim

Scott DeWire

Global Head of Business Development for Cancer Immunology
Boehringer Ingelheim

Scott is responsible for immuno-oncology partnerships and licensing at Boehringer Ingelheim Pharmaceuticals Inc.  Scott learned to pipette as an intern and later bench scientist with Pfizer Animal Health in his hometown of Groton, CT.  After Pfizer, he earned a PhD from the University of North Carolina, and completed his postdoc at Duke University with Robert Lefkowitz (2012 Nobel Prize).  Out of his postdoc, Scott co-founded Trevena Inc, a biotech company focused on GPCR biology.  Since joining Boehringer in 2012, Scott has held various roles in the research group before joining BD&L in 2016.

Scott has a lifelong love of animals, and he and his family currently have a menagerie of animals that includes his three cherished beagles.

 

Milton Boyle

Business Development
Boehringer Ingelheim Animal Health

Milton has over 30 years experience in animal agriculture and animal health.  He started his career as a commercial poultry geneticist and was head of R&D for 2 primary poultry breeders (Avian Farms International and Hubbard Farms).  Since 2007, he has worked for Merial and now Boehringer Ingelheim as the business development partner for R&D focusing on licenses and research collaborations.

Milton Boyle

Business Development
Boehringer Ingelheim Animal Health

Milton Boyle

Business Development
Boehringer Ingelheim Animal Health

Milton has over 30 years experience in animal agriculture and animal health.  He started his career as a commercial poultry geneticist and was head of R&D for 2 primary poultry breeders (Avian Farms International and Hubbard Farms).  Since 2007, he has worked for Merial and now Boehringer Ingelheim as the business development partner for R&D focusing on licenses and research collaborations.

 

Tyre Grant

Sr. Director, Global Food Animal Development
Elanco

Tyre Grant

Sr. Director, Global Food Animal Development
Elanco

Tyre Grant

Sr. Director, Global Food Animal Development
Elanco
Phage Directory Report
Phage Futures 2019 Highlights
 
2021 Microbiome Connect Nutrition
1-2 Jun 2021
VIRTUAL EVENT
Research into the gut microbiome has positioned the industry at the core of personalized nutrition and diet. With the global market of probiotics projected to be worth $64Bn by 2024 and a boom in consumer consciousness around wellness following the pandemic, a new wave of product development is occurring.Microbiome Connect: Nutrition is the second global event dedicated to transforming microbiome R&D into consumer products that promote wellbeing. Tune in to meet the nutrition ecosystem across; big nutrition, consumer Health, CPG companies, independent nutrition brands, ingredients producers and formulators. Key challenges and solutions being discussed include;Customer retention - Retain customers through gut microbiome personalized diagnosticsand regimes.Claims development - Develop a better understanding of the regulatory status of products and the claims that can be made and establish methodology for developing trials to establish new claims for their productsPartnerships - Network across the ecosystem leading to new product development partnerships, investment and supply-chain.Product development - Protecting IP and enaching product development and pipeline.Trend identification - Develop better consumer insights to determine the scientific language consumers and understand and what they will buy through spotting future trends. Utilize these learnings in the branding of marketing of your products.Join Microbiome Connect: Nutrition to meet with science and business leaders from the microbiome field to transform microbiome research and innovation into successful and effective consumer products.